Boothbay Fund Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-15,843
| Closed | -$409K | – | 639 |
|
|
2017
Q2 | $409K | Sell |
15,843
-10,333
| -39% | -$267K | 0.09% | 252 |
|
|
2017
Q1 | $503K | Buy |
+26,176
| New | +$503K | 0.09% | 207 |
|
|
2015
Q3 | – | Sell |
-9,798
| Closed | -$333K | – | 514 |
|
|
2015
Q2 | $333K | Buy |
9,798
+1,051
| +12% | +$35.7K | 0.13% | 131 |
|
|
2015
Q1 | $310K | Sell |
8,747
-14,149
| -62% | -$501K | 0.2% | 101 |
|
|
2014
Q4 | $390K | Buy |
+22,896
| New | +$390K | 0.3% | 78 |
|